Start / Cell & Gene: The Podcast / Inside solid tumor therapies with bluesphere bios ceo dr david apelian

Cell & Gene: The Podcast

Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian

25 min • 17 mars 2022

We love to hear from our listeners. Send us a message.

BlueSphere Bio's CEO Dr. David Apelian explains the difficulties associated with treating solid tumor cancers as well as what the CGT sector needs to get right in the short term and why.

Subscribe to the podcast!
Apple | Spotify | YouTube

Senaste avsnitt

Rethinking Large Animal Models in Gene Therapy with Novartis' Ralf Schmid, Ph.D.

17 juli | 25 min

Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath

3 juli | 20 min

Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews

19 juni | 16 min

Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka

5 juni | 25 min

Harnessing AI and Synthetic Biology for Cell Therapies with Generate:Biomedicines' Dr. Alex Snyder

22 maj | 19 min
Vad är en podd?

En liten tjänst av I'm With Friends. Finns även på engelska.

Podcastbild

00:00 -00:00
00:00 -00:00